Zobrazeno 1 - 10
of 10
pro vyhledávání: '"G L, Elfring"'
Autor:
M, Wilschanski, L L, Miller, D, Shoseyov, H, Blau, J, Rivlin, M, Aviram, M, Cohen, S, Armoni, Y, Yaakov, T, Pugatsch, T, Pugatch, M, Cohen-Cymberknoh, N L, Miller, A, Reha, V J, Northcutt, S, Hirawat, K, Donnelly, G L, Elfring, T, Ajayi, E, Kerem
Publikováno v:
The European respiratory journal. 38(1)
In a subset of patients with cystic fibrosis (CF), nonsense mutations (premature stop codons) disrupt production of full-length, functional CF transmembrane conductance regulator (CFTR). Ataluren (PTC124) allows ribosomal readthrough of premature sto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32178c8d84b0e2956dcda0fac685bdae
https://pubmed.ncbi.nlm.nih.gov/21233271
https://pubmed.ncbi.nlm.nih.gov/21233271
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group
Autor:
L B, Saltz, J V, Cox, C, Blanke, L S, Rosen, L, Fehrenbacher, M J, Moore, J A, Maroun, S P, Ackland, P K, Locker, N, Pirotta, G L, Elfring, L L, Miller
Publikováno v:
The New England journal of medicine. 343(13)
The combination of fluorouracil and leucovorin has until recently been standard therapy for metastatic colorectal cancer. Irinotecan prolongs survival in patients with colorectal cancer that is refractory to treatment with fluorouracil and leucovorin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4df76fc1bacc44e9efd5d30b2facb1a8
https://pubmed.ncbi.nlm.nih.gov/11450667
https://pubmed.ncbi.nlm.nih.gov/11450667
Autor:
M L, Rothenberg, J V, Cox, R F, DeVore, J D, Hainsworth, R, Pazdur, S E, Rivkin, J S, Macdonald, C E, Geyer, J, Sandbach, D L, Wolf, J S, Mohrland, G L, Elfring, L L, Miller, D D, Von Hoff
Publikováno v:
Cancer. 85(4)
This multicenter, Phase II trial was performed to evaluate the antitumor activity and toxicity of irinotecan (CPT-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-FU)-based chemotherapy.CPT-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69291afbc34eecc005de678b8b1a38d2
https://pubmed.ncbi.nlm.nih.gov/10091755
https://pubmed.ncbi.nlm.nih.gov/10091755
Autor:
Howard A. Burris, J. G. Kuhn, Mace L. Rothenberg, Allison Thurman, Geoffrey R. Weiss, David Rinaldi, John R. Eckardt, Lon Smith, G. L. Elfring, G. I. Rodriguez, L. J. Schaaf, James F. Nelson, D. D. Von Hoff, S. G. Eckhardt, Susan G. Hilsenbeck
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(4)
PURPOSE To evaluate irinotecan (CPT-11; Yakult Honsha, Tokyo, Japan) in patients with metastatic colorectal carcinoma that had recurred or progressed following fluorouracil (5-FU)-based therapy. PATIENTS AND METHODS Patients were treated with irinote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c4890dea45774a72c365a32e2f1726
https://pubmed.ncbi.nlm.nih.gov/8648367
https://pubmed.ncbi.nlm.nih.gov/8648367
Publikováno v:
Applied Microbiology. 15:363-367
The dose response curves of various turbidimetric microbiological assays, including vitamin B 12 , Ca pantothenate, and pyridoxine (vitamin B 6 ), were linear with logarithmic transformation of the responses by use of the equation derived, ln [ T ( x
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f29d8783224a87ca122d63b94c651a9f
https://doi.org/10.1128/am.15.2.363-367.1967
https://doi.org/10.1128/am.15.2.363-367.1967
Autor:
J P, McGovren, J C, Stewart, G L, Elfring, R B, Smith, N, Soares, J H, Wood, D G, Poplack, D D, Von Hoff
Publikováno v:
Cancer treatment reports. 66(6)
Acivicin was administered iv to rhesus monkeys bearing Ommaya reservoirs, and serial blood and cerebrospinal fluid (CSF) samples were collected and analyzed to determine the time course of drug concentrations in these body fluids. After iv doses of 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e8b58c2470b35ff4fe8c76c1b6131ee5
https://pubmed.ncbi.nlm.nih.gov/7083237
https://pubmed.ncbi.nlm.nih.gov/7083237
Autor:
P E, Byfield, C L, Barth, J A, Brodie, A B, Cosimi, S G, Dienst, A J, Elberg, G L, Elfring, M A, Hardy, H, Hayashi, S L, Kountz, K R, Lamborn, B E, Loughman, A, Sakai, P S, Satoh, C M, Zielinski, W J, Wechter
Publikováno v:
Transplantation proceedings. 10(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ee9a4ccc8b5b4d66437730d4a19e2df
https://pubmed.ncbi.nlm.nih.gov/362648
https://pubmed.ncbi.nlm.nih.gov/362648
Publikováno v:
Biometrics. 29(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::222d86d86d61ba99490b781b8fdc7d09
https://pubmed.ncbi.nlm.nih.gov/4709516
https://pubmed.ncbi.nlm.nih.gov/4709516
Autor:
G L, Elfring, J R, Schultz
Publikováno v:
Biometrics. 29(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd8eb20832b2320693efd439aa6d2f77
https://pubmed.ncbi.nlm.nih.gov/4599229
https://pubmed.ncbi.nlm.nih.gov/4599229
Autor:
J. R. Schultz, G. L. Elfring
Publikováno v:
Biometrics. 29:471
Group sequential procedures which are truly closed are developed for situations in which the probability of success for Treatment 1 is pi, that for Treatment 2 is P2, and the experimental objective is to test the hypothesis that pi = P2. The experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb64e5ea810cc6dfa0cd1194ea539e20
https://doi.org/10.2307/2529170
https://doi.org/10.2307/2529170